JFK Johnson Rehab’s Parkinson’s Wellness Program


Five Reasons for Hope (Johns Hopkins)


The Parkinson’s Foundation Research
Scientists have made a breakthrough in the development of a nasal spray for Parkinson’s disease treatment. (Health Europa Quarterly)
Researchers from the University of York have developed a new gel that can adhere to tissue inside the nose alongside the drug levodopa, helping deliver Parkinson’s disease treatment directly to the brain. The researchers created a gel, loaded with levodopa, that could flow into the nose as a liquid and then rapidly change to a thin layer of gel inside the nose. The method was tested in animal models by a team at King’s College London, where levodopa was successfully released from the gel into the blood and directly to the brain. Professor Smith said: “The results indicated that the gel gave the drug better adhesion inside the nose, which allowed for better levels of uptake into both the blood and brain.”
